What is he best known for?
The fields of study he is best known for:
His main research concerns Cell biology, Apoptosis, Jurkat cells, Programmed cell death and Fas ligand.
His work focuses on many connections between Cell biology and other disciplines, such as Cytotoxic T cell, that overlap with his field of interest in Cancer cell, Cytokine and Immunology.
His study in Apoptosis is interdisciplinary in nature, drawing from both Cell, Intracellular parasite and Virology.
His Jurkat cells research integrates issues from Caspase 3 and Molecular biology.
His work carried out in the field of Programmed cell death brings together such families of science as Autophagy, Ceramide, Autolysosome and Cancer research.
The Fas ligand study combines topics in areas such as T cell, Cell culture and Secretion.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. (250 citations)
- How Do Cytotoxic Lymphocytes Kill Cancer Cells (244 citations)
What are the main themes of his work throughout his whole career to date?
Alberto Anel mainly focuses on Apoptosis, Cell biology, Cytotoxic T cell, Programmed cell death and Cancer research.
Alberto Anel combines subjects such as Tumor necrosis factor alpha, Jurkat cells, Cell culture and Cytokine with his study of Apoptosis.
His studies in Cell biology integrate themes in fields like T cell, Cell, Granzyme and GZMB.
His work deals with themes such as Molecular biology, CD8 and Immunology, which intersect with Cytotoxic T cell.
His Necroptosis study, which is part of a larger body of work in Programmed cell death, is frequently linked to Farnesyltransferase inhibitor, bridging the gap between disciplines.
His Cancer research study integrates concerns from other disciplines, such as Multiple myeloma, Receptor, Cytotoxicity, In vivo and Immunotherapy.
He most often published in these fields:
- Apoptosis (40.16%)
- Cell biology (36.07%)
- Cytotoxic T cell (31.15%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (24.59%)
- Immune system (10.66%)
- Cytotoxic T cell (31.15%)
In recent papers he was focusing on the following fields of study:
Cancer research, Immune system, Cytotoxic T cell, Immunotherapy and Cell biology are his primary areas of study.
His Cancer research study incorporates themes from Natural killer cell, Cytotoxicity, Immune checkpoint inhibitors, Adoptive Cell Immunotherapy and Multiple myeloma.
His Immune system study frequently intersects with other fields, such as Programmed cell death.
He has researched Cytotoxic T cell in several fields, including Cell culture, Apoptosis and In vivo.
Many of his research projects under Apoptosis are closely connected to In patient with In patient, tying the diverse disciplines of science together.
His research in Cell biology intersects with topics in Cancer cell, Oxidative phosphorylation and Enzyme.
Between 2017 and 2021, his most popular works were:
- Immunogenic Cell Death and Immunotherapy of Multiple Myeloma. (56 citations)
- Role of Exosomes in the Regulation of T-Cell Mediated Immune Responses and in Autoimmune Disease (47 citations)
- Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors (16 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Immune system
His scientific interests lie mostly in Cell biology, Immune system, Programmed cell death, Cancer research and Tumor necrosis factor alpha.
The Cell biology study combines topics in areas such as Oxidative stress, Oxidative phosphorylation and Enzyme.
His Immune system research incorporates elements of Unfolded protein response, Obinutuzumab, Cancer and Necroptosis.
His Programmed cell death research is multidisciplinary, incorporating perspectives in T cell, Autoimmune disease, Autoimmunity and Cytokine.
The concepts of his Cancer research study are interwoven with issues in Cell, Proteasome, Immunogenic cell death, Cytotoxicity and Monoclonal antibody.
His Tumor necrosis factor alpha research includes themes of Transmembrane protein, Receptor, Ligand, Cancer cell and Apoptosis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
